Details of the Drug

General Information of Drug (ID: DMUGBRV)

Drug Name

PF-06293620

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02211261) A Phase 1 Single Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus. U.S. National Institutes of Health.